Using a bioinformatics and experimental approach, scientists at EPFL have found that rendering mitochondria resistant to damage can halt diseases caused by amyloid toxicity, such as Alzheimer’s disease. The study is published in Nature.
Alzheimer’s disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called beta-amyloid inside neurons.
Still without cure, Alzheimer’s poses a significant burden on public health systems. Most treatments focus on reducing the formation of amyloid plaques, but these approaches have been inconclusive. As a result, scientists are now searching for alternative treatment strategies, one of which is to consider Alzheimer’s as a metabolic disease.
Taking this line of thought, Johan Auwerx’s lab at EPFL looked at mitochondria, which are the energy-producing powerhouses of cells, and thus central in metabolism. Using worms and mice as models, they discovered that boosting mitochondria defenses against a particular form of protein stress, enables them to not only protect themselves, but to also reduce the formation of amyloid plaques.
During normal aging and age-associated diseases such as Alzheimer’s, cells face increasing damage and struggle to protect and replace dysfunctional mitochondria. Since mitochondria provide energy to brain cells, leaving them unprotected in Alzheimer’s disease favors brain damage, giving rise to symptoms like memory loss over the years.
The scientists identified two mechanisms that control the quality of mitochondria: First, the “mitochondrial unfolded protein response” (UPRmt), which protects mitochondria from stress stimuli. Second, mitophagy, a process that recycles defective mitochondria. Both these mechanisms are the key to delaying or preventing excessive mitochondrial damage during disease.
While we have known for a while that mitochondria are dysfunctional in the brains of Alzheimer’s patients, this is the first evidence that they actually try to fight the disease by boosting quality control pathways. “These defense and recycle pathways of the mitochondria are essential in organisms, from the worm C. elegans all the way to humans,” says Vincenzo Sorrentino, first author of the paper. “So we decided to pharmacologically activate them.”
The team started by testing well-established compounds, such as the antibiotic doxycycline and the vitamin nicotinamide riboside (NR), which can turn on the UPRmt and mitophagy defense systems in a worm model (C. elegans) of Alzheimer’s disease. The health, performance and lifespan of worms exposed to the drugs increased remarkably compared with untreated worms. Plaque formation was also significantly reduced in the treated animals.
And most significantly, the scientists observed similar improvements when they turned on the same mitochondrial defense pathways in cultured human neuronal cells, using the same drugs.
The encouraging results led the researchers to test NR in a mouse model of Alzheimer’s disease. Just like C. elegans, the mice saw a significant improvement of mitochondrial function and a reduction in the number of amyloid plaques. But most importantly, the scientists observed a striking normalization of the cognitive function in the mice. This has tremendous implications from a clinical perspective.
According to Johan Auwerx, tackling Alzheimer’s through mitochondria could make all the difference. “So far, Alzheimer’s disease has been considered to be mostly the consequence of the accumulation of amyloid plaques in the brain,” he says. “We have shown that restoring mitochondrial health reduces plaque formation – but, above all, it also improves brain function, which is the ultimate objective of all Alzheimer’s researchers and patients.”
The strategy provides a novel therapeutic approach to slow down the progression of neurodegeneration in Alzheimer’s disease, and possibly even in other disorders such as Parkinson’s disease, which is also characterized by profound mitochondrial and metabolic defects.
The approach remains to be tested in human patients. “By targeting mitochondria, NR and other molecules that stimulate their ‘defense and recycle’ systems could perhaps succeed where so many drugs, most of which aim to decrease amyloid plaque formation, have failed,” says Vincenzo Sorrentino.
Learn more: Healthy mitochondria could stop Alzheimer’s
The Latest on: Rendering mitochondria resistant to damage
[google_news title=”” keyword=”rendering mitochondria resistant to damage” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Ready. Aim. Fire: Mitochondria as Treatment Targetson May 7, 2024 at 7:44 am
Boosting mitochondrial function is about to revolutionize psychiatric treatment—and some metabolic strategies are readily accessible now.
- Metastatic Castration-resistant Prostate Canceron May 5, 2024 at 5:00 pm
Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The understanding of the biology of CRPC and the evidence that CRPC still remains driven by ...
- How Much Does Roof Repair Cost In 2024?on May 2, 2024 at 3:12 am
If you put off repairs for too long, the damage can get much worse ... Metal roofs are highly durable and wind- and water-resistant, usually lasting for 40 to 70 years or more with proper maintenance.
- Dragon's Dogma 2: Best Armor For Ice Damage Resistanceon April 10, 2024 at 5:00 pm
Dragon's Dogma 2 players should seek out the following armor if they're in need of protection from ice damage. Equip a wide range of armor to specialize in resisting ice damage in Dragon's Dogma 2 ...
- Drug-Resistant Infections: A Threat to Our Economic Futureon April 4, 2024 at 8:49 pm
Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective ... this report underscores that the likely direct and indirect economic damage would be ...
- New Insights Suggest Early Prediction of Parkinson’s Disease May Be Possible Through Mitochondrial DNA Damageon April 2, 2024 at 8:16 pm
This mtDNA is exposed to the toxic by-products of energy production, making it particularly susceptible to damage. Neurons, with their high energy usage, rely heavily on mitochondrial efficiency ...
- Unveiling mitochondrial mysteries to conquering cancer therapy resistanceon March 19, 2024 at 1:46 am
Intriguingly, their investigations revealed a common point for resistance induced by various drugs: the mitochondria. They observed a reduction in mitochondrial apoptotic priming, a phenomenon ...
- From KiCad To Blender For A Stunning Renderon January 2, 2024 at 9:14 pm
In short, Blender is about all things art and visual expression. Now, what if you want a breathtaking render of your KiCad board? Look no further than the pcb2blender tool from [Bobbe 30350n].
- Resistance to Evidenceon August 24, 2023 at 12:20 am
We have increasingly sophisticated ways of acquiring and communicating knowledge, but efforts to spread this knowledge often encounter resistance to evidence. The phenomenon of resistance to evidence, ...
- Transmitochondrial mice carrying resistance to chloramphenicol on mitochondrial DNA: Developing the first mouse model of mitochondrial DNA diseaseon May 16, 2022 at 7:26 am
Two males and two females have been analyzed for levels of wild-type and chloramphenicol-resistant mitochondria. CAPr mtDNA was detectable in many tissues at levels as high as 6% of total mtDNA (Fig.
via Google News and Bing News